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doi:10.1016/j.numecd.2007.12.003Abstract Background and aims: Postprandial lipoprotein abnormalities in type 2 diabetes are
associated with insulin resistance. The role of other diabetes-related factors is still not clear.
The aim of this study is to differentiate the effects of whole-body insulin resistance, obesity,
and type 2 diabetes on postprandial dyslipidaemia and lipoprotein lipase (LPL) in adipose
tissue.
Methods and results: Ten subjects with obesity and diabetes (OD), 11 with obesity alone (O),
and 11 normal-weight controls (C) e males, aged 26e59 years, with fasting normo-triglyceri-
daemia underwent measurements of cholesterol, triglycerides, apo B-48 and apo B-100 con-
centrations in plasma lipoproteins separated by density gradient ultracentrifugation before
and after a fat-rich meal. Fasting and postprandial (6 h) LPL activity was determined in abdom-
inal subcutaneous adipose tissue biopsy samples. Insulin sensitivity was measured by hyperin-
sulinaemic euglycaemic clamp. OD and O subjects had similar degrees of adiposity (BMI, waist
circumference, fat mass) and insulin resistance (insulin stimulated glucose disposal and M/I ).
They also showed a similarly higher postprandial increase in large VLDL lipids (triglyceride in-
cremental AUC 188  28 and 135  22 mg/dl$6 h) than C (87  13 mg/dl$6 h, M  SEM,
p< 0.05). OD had an increased chylomicron response compared to O (triglyceride incremental
AUC 132 23 vs. 75 14 mg/dl$6 h, p< 0.05). OD had significantly lower fasting and postpran-
dial adipose tissue heparin-releasable LPL activity than O and C.1 7462311; fax: þ39 081 5466152.
G. Annuzzi).
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532 G. Annuzzi et al.Conclusions: In insulin-resistant conditions of obesity, with and without diabetes, large VLDL
are increased after a fat-rich meal. In addition, diabetic patients compared to obese subjects
have an increased postprandial chylomicron response and a reduced adipose tissue LPL
activity.
ª 2008 Elsevier B.V. All rights reserved.Table 1 Physical characteristics, fasting metabolic
values, insulin sensitivity measures, and adipose tissue
heparin-releasable LPL activity of the subjects participating
in the study
Diabetic
obese
Obese Controls
Male (n) 10 11 11
Age (years) 45.6 [6.4] 45.8 [8.7] 39.1 [8.3]
Anthropometrics
BMI (kg/m2)a 32.8 [2.0]b 34.5 [2.7]b 24.0 [1.3]
Waist circumference
(cm)a
112 [8]b 113 [7]b 85 [4]
Body fat mass (kg)a 31.7 [4.4]b 32.9 [4.9]b 13.1 [1.4]
Fasting plasma values
Cholesterol (mg/dl) 175 [24] 187 [35] 160 [24]
Triglycerides (mg/dl) 103 [24] 99 [34] 78 [27]
HDL cholesterol (mg/dl)a 35 [4]b,c 43 [11] 47 [10]
Glucose (mg/dl)a 131 [36]b,c 90 [9] 86 [9]
Hyperinsulinemic
euglycemic clamp
Glucose infusion
rate (M value)
(mg/kg b.w./min)a
4.1 [0.9]b 4.5 [1.5]b 8.2 [2.2]
M/Ia 2.1 [1.1]b 1.7 [0.8]b 7.5 [3.2]
Adipose tissue LPL
activity (nmol FA/g/h)a
Fasting 99 [34]b,c 217 [92] 252 [155]
6 h after meal 89 [51]b,c 231 [99] 278 [130]
Data are presented as M [SD].
a p< 0.05 ANOVA.
b p< 0.05 vs. controls.
c p< 0.05 vs. obese.Introduction
Postprandial lipoprotein abnormalities are associated with
an increased risk of coronary heart disease [1]. These ab-
normalities are more frequent in individuals with obesity,
type 2 diabetes or other conditions characterized by insulin
resistance [2e6].
Whether specific abnormalities of postprandial lipopro-
tein metabolism are present in patients with type 2
diabetes, however, is not clear [7]. These patients also ex-
hibit postprandial abnormalities in the presence of fasting
normo-triglyceridaemia [2,3]. Moreover, abnormalities con-
cern both exogenous and endogenous triglyceride-rich
lipoproteins, since the number of both apolipoprotein
(apo) B-48 and apo B-100 particles in large VLDL fraction
is increased after a fat-rich meal [3].
The cause/s of these abnormalities has not been de-
fined. There are many indications that postprandial dysli-
pidaemia in type 2 diabetes is associated with insulin
resistance. This is suggested by studies showing postpran-
dial lipid abnormalities in insulin-resistant conditions, in
first-degree relatives of type 2 diabetic patients [6],
smokers [5], obese individuals [8] and non diabetic individ-
uals with insulin resistance [4,9]. In patients with type 2 di-
abetes postprandial lipoprotein abnormalities were also
present when the confounding effects of hyperglycaemia
and hyperinsulinaemia were avoided by evaluating post-
prandial lipemia during a hyperinsulinaemic glycaemic
clamp [10].
However, this remains to be confirmed in a chronic
setting comparing diabetic patients with individuals with
the same level of insulin resistance.
Mechanisms responsible for the altered postprandial
lipoprotein profile in type 2 diabetes are also very much
debated, with controversial results concerning the role of
lipoprotein lipase (LPL), the key enzyme in the intravascu-
lar catabolism of triglyceride-rich lipoproteins. Discrep-
ancies arise from differences in the type of sample,
reflecting a different tissue origin of LPL, as well as from
the confounding effect of the strict associations between
diabetes, insulin resistance and obesity. Adipose tissue is
central to these conditions and, at the same time, it has
been suggested to be essential in postprandial removal and
partitioning of exogenous fat [11].
Therefore, the aims of this study were to characterize
postprandial dyslipidaemia of type 2 diabetes evaluating (a)
the role of insulin resistance e comparing obese subjects
with and without type 2 diabetes vs. normal-weight con-
trols, (b) any additional effect of diabetes per se e compar-
ing obese diabetic vs. only obese subjects, and (c) the
role of adipose tissue LPL in the aetiology of these
abnormalities.Methods
Subjects
Ten patients with type 2 diabetes mellitus and obesity, 11
patients with only obesity, 11 normal-weight control sub-
jects participated in the study. Their baseline charac-
teristics are shown in Table 1. Subjects were males, aged
26e59 years, and had normal fasting plasma concentra-
tions of both triglycerides (<150 mg/dl) and cholesterol
(<210 mg/dl).
The subjects had no history or symptoms of any known
disease, apart from diabetes, nor were they vegetarians or
engaged in intensive physical activity. They were not taking
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glycaemic control on diet alone (HbA1cZ 6.5 1.4%). The
study protocol was approved by the Federico II University
Ethics Committee and informed consent was obtained
from all participants.
Experimental procedures
In the morning after a 12-h fast, anthropometric measure-
ments and bioimpedentiometry were performed before
subjects were given a standard meal. Before the meal
and over the following 6 h blood samples were taken for de-
termination of plasma levels of glucose, insulin, C-peptide,
NEFA, lipids and lipoproteins, apo B-48 and apo B-100. Six
hours after the meal a needle biopsy of abdominal subcuta-
neous adipose tissue was taken for the determination of
LPL activity. A similar biopsy in the opposite side of lower
abdomen was taken at fast 1e7 days apart. Subjects also
underwent a hyperinsulinaemic euglycaemic clamp.
Anthropometry and body composition
Body weight, height, and waist circumference were mea-
sured according to standardized procedures [12]. Fat-free
body mass (FFM) was determined by bioimpedentiometry
[13]. Fat mass was calculated subtracting FFM from body
weight.
Standard test meal
The standard meal (944 kcal; 31% carbohydrates, 57% fat
(34% saturated), and 12% protein) consisted of a pie made
of mashed potato, whole milk, egg, cheese, ham and but-
ter, to be consumed in around 15 min.
Hyperinsulinaemic euglycaemic clamp [14]
Regular human insulin was administered intravenously at
a constant rate of 1.5 mU kg body weight1 min1 for 2 h.
Blood glucose concentrations were maintained around
90 mg/dl by adjusting the glucose infusion rate according
to blood glucose measurements on an Accucheck analyser
(Roche, Switzerland). As measures of whole-body insulin
sensitivity, mean glucose infusion rate during the last
30 min of the clamp (M value) and M/I ratio (M value di-
vided by the corresponding plasma insulin concentrations)
were calculated.
Laboratory procedures
Lipoprotein separation
Samples were kept at þ4 C before, during and after centri-
fugation and treated to minimize proteolytic degradation
of apo B [3]. Fasting and postprandial lipoprotein subfrac-
tions were isolated by discontinuous density gradient ultra-
centrifugation according to Refs. [15,16], as previously
described [3]. Briefly, three consecutive runs were per-
formed at 15 C and at 40 000 rpm to float: chylomicrons
(Svedberg flotation unit (Sf) >400), large VLDL (Sf 60e
400) and small VLDL (Sf 20e60). IDL (Sf 12e20) and LDL
(Sf 0e12) were recovered from the gradient after the Sf
20e60 particles had been collected. HDL was isolated by
a precipitation method.Apo B-48 and apo B-100
Concentrations of apo B-48 and apo B-100 were determined
in chylomicrons, large VLDL and small VLDL fractions by SDS-
PAGEona self-made 3.5e20% gel gradient according to Karpe
and Hamsten [17], as previously described [3]. The intra- and
inter-gel coefficients of variation were 10.1% and 13.7% for
apo B-48 and 6.9% and 12.3% for apo B-100, respectively.
Adipose tissue LPL activity
LPL heparin-releasable activity was determined as modified
from Taskinen et al. [18]. Small pieces (5e10 mg) of frozen
adipose tissue were incubated in duplicate in small vials for
45 min at 37 C, 70 cycles/min, with 450 ml of 0.1 mol/l
KrebseRinger Tris buffer, pH 8.4 (containing 1 g/100 ml bo-
vine albumin and 45 ml pooled normal human serum) and
50 ml of beef lung heparin (50 units/ml saline). Thereafter,
tissue pieces were removed and 100 ml eluate, in triplicate
for each vial, were incubated with the same volume of a 3H-
trioleoylglycerol substrate emulsion stabilized by dioleoyl
phosphatidyl choline [19] for 110 min at 37 C. The 3H-la-
belled oleic acid released was extracted by Belfrage and
Vaughan mixture, shaken for 4 min and centrifuged at
3000 rpm, 20 min, 20 C. 1.6 ml of the supernatant containing
releasedoleic acid in10 ml InstagelPluswascounted for1 h in
a Wallac 1410 Liquid Scintillation Counter.
Other measurements
Plasma concentrations of cholesterol, triglyceride and NEFA
were assayed by enzymatic colorimetric methods (Roche
Molecular Biochemicals, Mannheim, Germany), insulin and
C-peptide by ELISA (Technogenetics, Milan, Italy).
Statistical analysis
Data are expressed as mean SEM, unless otherwise stated.
Postprandial incremental area was calculated by the trape-
zoidal method as the area under the curve above baseline
value (IAUC). Differences between the three groups were
evaluated by ANOVA and by post hoc test between groups
(LSD). Differences between the three groups at single time
points after the meal were first evaluated by ANOVA for re-
peated measures. Variables not normally distributed were
analyzed after logarithmic transformation or by nonpara-
metric tests. Two-tailed tests were used and a p< 0.05 was
considered statistically significant. Statistical analysis was
performed using the Statistical Package for Social Sciences
software (SPSS/PC, SPSS, Inc., Chicago, IL).
Results
Anthropometrics (Table 1)
Obese and diabetic obese subjects had similarly high BMI
and abdominal circumference, with a similar body compo-
sition as shown by their fat mass.
Whole-body insulin sensitivity (Table 1)
Glucose infusion rate during the last 30 min of the eugly-
caemic hyperinsulinaemic clamp (M value) was similarly
lower in the two obese groups compared to controls
534 G. Annuzzi et al.(p< 0.001). The impairment in insulin sensitivity was high-
lighted when M values were corrected for the concomitant
plasma insulin levels (M/I ratios) (p< 0.001).
Fasting and postprandial glucose, insulin, C-peptide
and NEFA concentrations (Fig. 1)
Bloodglucose levelswerehigher in thediabetic subjects both
at fasting and after the meal (p< 0.01 at all time points).
Fasting and postprandial plasma insulin levels were
significantly higher in obese subjects with and without
diabetes compared to controls (p< 0.01 at all time points).
Compared to obese subjects, diabetic subjects showed
a tendency to a blunted early insulin response (2 h after
the meal). Plasma C-peptide concentrations showed a pro-
file similar to insulin.
Fasting plasma NEFA levels were not significantly differ-
ent between the three groups. NEFA levels were suppressed
2 h after the meal, with a tendency to a lower suppression
in diabetic subjects.
Lipids and apo B concentrations
Whole plasma
Fasting plasma triglycerides and cholesterol concentrations
were not significantly different between the three groups
(Table 1). Postprandial IAUC for triglycerides was higher
in diabetic subjects compared to obese and controls
(p< 0.05) (Table 2). Cholesterol levels decreased postpran-
dially, without differences between groups (Table 2).0
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Figure 1 Plasma concentrations of glucose, insulin, C-peptide
squares), diabetic obese (white triangles), and normal-weight con
vs. obese.Chylomicrons (Fig. 2)
Diabetic patients had higher levels of postprandial chylomi-
cron lipids compared to the other two groups, the differ-
ences being significant at 6 h for both triglycerides and
cholesterol (p< 0.05 vs. obese). Diabetic patients also
showed significantly higher triglycerides IAUC (p< 0.05 vs.
obese) and cholesterol IAUC (p< 0.05 vs. obese and con-
trols) (Table 2). Apo B-48 levels at 6 h were also increased
in diabetic subjects compared to the obese ones
(p< 0.05). Apo B-100 levels, both before and after the
meal, were not different between the three groups.
Large VLDL (Fig. 3, Table 2)
Fasting concentrations of triglycerides, cholesterol, and
apo B-100 in this fraction were higher (albeit not signifi-
cantly) in obese and diabetic obese compared to controls.
After the meal, triglycerides, cholesterol, and apo B-100
concentrations increased more in the two obese groups,
the differences being significant in the late postprandial
phase. A greater IAUC was observed for triglycerides
(188 28 and 135 22 in diabetic and obese subjects, re-
spectively, vs. 87 13 mg/dl$6 h in controls, ANOVA
pZ 0.011), and cholesterol (25.6 3.9 and 19.2 3.3 vs.
10.0 2.0 mg/dl$6 h in controls, ANOVA pZ 0.006). In con-
trast, apo B-100 IAUC was not significantly different in the
three groups (ANOVA pZ 0.513). There was a trend to
higher postprandial apo B-48 in the diabetic subjects.
In the three groups combined, IAUCs of triglyceride and
cholesterol large VLDL were inversely correlated with the
insulin sensitivity indexM/I (rZ0.48, pZ 0.009 for both).0
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Table 2 Incremental AUC for triglycerides (TG) (mg/dl$6 h), cholesterol (Chol) (mg/dl$6 h), apo B-48 (mg/l$6 h), and apo B-
100 (mg/l$6 h) in whole plasma and lipoprotein fractions after a standard meal in diabetic obese, obese, and normal-weight
control subjects
Diabetic obese Obese Controls
Whole plasma TG 343 [52]b,c 222 [37] 208 [34]
Chol 8.7 [9.9] 16.6 [9.7] 14.3 [7.3]
Chylomicrons TG 132 [23]c 75 [14] 107 [20]
Chol 5.1 [0.9]b,c 3.1 [0.6] 3.1 [0.5]
B-48 0.48 [0.22] 0.13 [0.04] 0.27 [0.12]
B-100 1.5 [0.7] 0.78 [0.35] 0.42 [0.22]
Large VLDL TGa 188 [28]b 135 [22]b 87 [13]
Chola 25.6 [3.9]b 19.2 [3.3]b 10.0 [2.0]
B-48 5.0 [1.4] 3.3 [0.7] 3.0 [1.1]
B-100 61 [23] 80 [18] 51 [12]
Small VLDL TGa 11.9 [5.3]b 2.9 [4.0] 3.5 [3.3]
Chol 5.2 [2.8]b 0.3 [1.3] 0.01 [1.6]
B-48 0.9 [0.5] 2.2 [1.1] 1.0 [0.5]
B-100 10.8 [13.7] 33.6 [23.9] 15.6 [9.1]
IDL TG 3.0 [1.2] 3.3 [1.3] 0.9 [1.1]
Chol 1.8 [1.5] 6.7 [2.3] 1.8 [1.7]
LDL TG 5.7 [2.2] 6.2 [2.3] 2.1 [1.0]
Chol 24.1 [7.1] 16.0 [12.3] 16.9 [7.4]
HDL TG 2.1 [4.9] 0.2 [2.9] 6.6 [7.3]
Chol 10.1 [2.3] 12.3 [5.9] 10.4 [3.1]
Data are presented as M [SEM].
a p< 0.05 ANOVA.
b p< 0.05 vs. controls.
c p< 0.05 vs. obese.
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Fasting lipids and apo B concentrations in this fraction were
higher in the obese and diabetic obese compared to
controls (data not shown). A slight postprandial decrease
in triglyceride and cholesterol was present in the diabetic
group, as shown by significantly lower IAUCs compared to
controls (Table 2).
IDL, LDL and HDL
Fasting HDL cholesterol concentrations were significantly
lower in subjects with diabetes compared to obese and
control subjects (Table 1). The changes induced by the
meal in IDL, LDL and HDL fractions did not significantly dif-
fer between the three groups (Table 2).
Adipose tissue LPL activity
Heparin-releasable LPL activity, expressed per gram of
adipose tissue, was significantly lower in the diabetic
subjects at fast (99 11 vs. 217 35 and 252 51 nmol
FA/g/h, in obese and controls, respectively, ANOVA
p< 0.05) and after meal (89 16 vs. 231 31 and
278 40 nmol FA/g/h, ANOVA p< 0.01) (Table 1). LPL activ-
ity was lower in subjects with diabetes, also when expressed
per total fat mass. In the three groups combined, postpran-
dial LPL activity was inversely correlated with postprandial
IAUC of chylomicron triglycerides (rZ0.42, p< 0.05).Discussion
While long being recognized, postprandial lipid abnormal-
ities in diabetes, namely the specific types of lipoproteins
affected and the mechanisms involved, are still not fully
characterized. There are several reasons for these incon-
sistencies. Few studies have performed a thorough evalu-
ation of postprandial lipoprotein fractions, including apo
B-48 and apo B-100 measurements; fasting hypertriglycer-
idaemia has not always been taken into account as a
confounding factor; patients with different degrees of
blood glucose control and who were overweight have
been studied, and insulin sensitivity has seldom been
quantified. Paying attention to these factors, we have
dealt with a relevant unsolved issue, i.e. the specific
effects of diabetes per se, obesity per se and whole-body
insulin resistance on individual postprandial lipoprotein
alterations.
The first finding of this study defines the increase in
large VLDL as the quantitatively most relevant postprandial
alteration in obese and diabetic patients with fasting
normo-triglyceridaemia. This abnormality was associated
with insulin resistance since it was similarly observed in
obese individuals with and without diabetes at comparable
levels of whole-body insulin resistance. It mainly repre-
sented lipoproteins of endogenous origin, as shown by the
higher postprandial levels of apo B-100, which completely
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Figure 2 Concentrations of triglyceride, cholesterol, apo B-48, and apo B-100 in plasma chylomicrons before and after a standard
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Figure 3 Concentrations of triglyceride, cholesterol, apo B-48, and apo B-100 in plasma large VLDL before and after a standard
meal in obese (white squares), diabetic obese (white triangles), and normal-weight controls (black circles). M SEM; *p< 0.05 vs.
controls.
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Diabetes, obesity, and postprandial lipids 537overlapped in obese individuals with and without diabetes.
The higher postprandial apo B-100 levels were not directly
due to changes induced by the meal, as IAUCs only
marginally differed in the three groups, but rather to the
fact that apo B-100 levels were already higher in the fasting
condition in insulin-resistant subjects compared with con-
trols, confirming our previous observation [3]. This also in-
dicates that in individuals with normo-triglyceridaemia,
large VLDL postprandial alterations are related to fasting
levels as well as to hepatic insulin resistance.
The second novel finding of this study is that, in addition
to large VLDL abnormalities, diabetic patients had higher
levels of exogenous triglyceride-rich lipoproteins than
obese individuals without diabetes. The chylomicron in-
crease was therefore related to diabetes ‘‘per se’’ and
independent of whole-body insulin resistance. It is intrigu-
ing that the chylomicron response in simply obese in-
dividuals was even lower than that of normal-weight
controls. This is nevertheless in agreement with previous
studies showing similar/lower postprandial chylomicron
lipids in normotriglyceridaemic obese individuals compared
to normal-weight controls [20,21], and in line with the pro-
posed ‘‘buffering’’ action of adipose tissue in the postpran-
dial phase [11]. Adipose tissue could functionally act as
a reservoir for the ingested fat, diverting it from other tis-
sues where it wouldn’t be necessary and therefore poten-
tially deleterious. This process could be more active in
individuals with simple obesity due to their prevailing
higher peripheral insulin levels.
The higher chylomicron response in the diabetic sub-
jects could be related to the lower LPL activity in adipose
tissue we found in these patients. This possibility is
supported by the inverse correlation observed between
these two parameters. The role of LPL activity in the
genesis of postprandial dyslipidaemia has been difficult to
assess because of differences in type of meal and timing
and, especially, source of sampling. In fact, there is
a mixed contribution in plasma by tissues e mainly
muscle and adipose tissue e with opposing postprandial
behaviours [22]. In our study, diabetic subjects had a sig-
nificant reduction of LPL activity in adipose tissue com-
pared to subjects with a similar degree of adiposity,
when the activity was expressed either per weight or
per total body fat. This is in line with the results of a pre-
vious study in the fasting condition [23]. On the other
hand, Eriksson et al. [24] showed that adipose tissue
LPL activity was not significantly different between pa-
tients with type 2 diabetes and healthy controls, matched
for age, gender and BMI. Reasons for this difference may
be that in the latter study subjects were not obese and
less homogeneous as for diabetes treatment and blood
glucose control.
The LPL defective action in the diabetic subjects may
also explain their slight reduction in small VLDL lipids after
the meal, indicating a slower postprandial lipoprotein
cascade also concerning the catabolism of larger particles
to small VLDL.
We observed no changes in LPL activity between fasting
and 6 h after the meal. Apart from the late postprandial
sampling time, 6 h vs. 3.5e4 h as more often done, this
may also be due to the type of stimulus, i.e., a fat-rich
meal. In fact, an increased LPL activity is observed afterglucose ingestion but not after fat ingestion [25]. In com-
paring fasting and post-meal LPL activities it must also be
considered that fasting and postprandial biopsies were
taken on different days, although all other conditions
were kept unchanged between the two occasions.
Which factor/s may induce lower LPL activity is not
known. LPL is an insulin sensitive enzyme, and in humans
insulin increases adipose tissue LPL [26]. Therefore, it is
possible that the higher plasma insulin levels in both insu-
lin-resistant groups were unable to compensate in the
case of diabetic subjects, who showed a blunted early post-
prandial insulin response compared to the only obese ones.
Moreover, the first postprandial sample was taken 2 h after
the meal and therefore we could have missed the largest
difference between the two groups. As to the relevance
of early insulin response, studies in rats have shown a cen-
tral role of insulin in the postprandial response of adipose
tissue LPL, that was also stimulated by early cephalically
mediated insulin secretion [27].
The possible role of hyperglycaemia in the explanation
of the lower LPL activity in diabetic patients must be
considered, it being the main parameter discriminating
between diabetic and obese subjects. As a matter of fact,
LPL activity was increased in adipose tissue by improved
diabetes control [28,29] and decreased in the circulation by
hyperglycaemia [30].
In conclusion, this study elucidates types and possible
mechanisms of postprandial lipid abnormalities in individ-
uals with obesity and type 2 diabetes without fasting
hypertriglyceridaemia. In these individuals the quantita-
tively most relevant alteration is an increase in hepatic
large VLDL, which reflects the higher fasting levels of this
fraction and is likely to be related to insulin resistance. In
addition, diabetes per se is characterized by an increased
postprandial chylomicron response, independent of obesity
and whole-body insulin resistance, likely to be a conse-
quence of the reduced adipose tissue LPL activity. Although
the diabetic patients participating in this study do not
represent the whole diabetic population, as they were
selected in good glycaemic control and with fasting normo-
triglyceridaemia, it may be assumed that in the clinical
setting these postprandial lipoprotein alterations will be
even more evident.
Differences in postprandial abnormalities and related
mechanisms imply that multiple therapeutic approaches be
considered to correct the abnormal postprandial lipid
metabolism in patients with obesity and diabetes mellitus,
in order to potentially reduce their negative cardiovascular
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